BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33758143)

  • 21. Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.
    Cavalcanti E; Armentano R; Valentini AM; Chieppa M; Caruso ML
    Cell Death Dis; 2017 Aug; 8(8):e3004. PubMed ID: 28837143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G; La Rosa S
    Virchows Arch; 2018 Mar; 472(3):341-349. PubMed ID: 29134440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
    Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
    Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grading and Prognostication of Neuroendocrine Tumors of the Pancreas: A Comparison Study of Ki67 and PHH3.
    Tracht J; Zhang K; Peker D
    J Histochem Cytochem; 2017 Jul; 65(7):399-405. PubMed ID: 28651471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.
    Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M
    Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.
    Nielsen PS; Riber-Hansen R; Jensen TO; Schmidt H; Steiniche T
    Mod Pathol; 2013 Mar; 26(3):404-13. PubMed ID: 23174936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
    Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of an Image-based Automated Detection System in Detecting Ki67 Proliferation Index and Correlation with the Traditional Eye-Ball Method in Gastroenteropancreatic Neuroendocrine Tumors.
    Dere Y; Ozkaraca O; Cetin G; Dere O
    J Coll Physicians Surg Pak; 2019 Feb; 29(2):137-140. PubMed ID: 30700352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of a Cytotechnologist Manual Counting Service for the Ki67 Index in Neuroendocrine Tumors of the Pancreas and Gastrointestinal Tract.
    Cottenden J; Filter ER; Cottreau J; Moore D; Bullock M; Huang WY; Arnason T
    Arch Pathol Lab Med; 2018 Mar; 142(3):402-407. PubMed ID: 29293020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): what's better?
    Milione M
    Endocrine; 2018 Jan; 59(1):1-3. PubMed ID: 28417314
    [No Abstract]   [Full Text] [Related]  

  • 31. Synaptophysin-Ki67 double stain: a novel technique that improves interobserver agreement in the grading of well-differentiated gastrointestinal neuroendocrine tumors.
    Matsukuma K; Olson KA; Gui D; Gandour-Edwards R; Li Y; Beckett L
    Mod Pathol; 2017 Apr; 30(4):620-629. PubMed ID: 28084345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of visual assessments of proliferation indices in gastroenteropancreatic neuroendocrine tumours.
    Young HT; Carr NJ; Green B; Tilley C; Bhargava V; Pearce N
    J Clin Pathol; 2013 Aug; 66(8):700-4. PubMed ID: 23703851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Clinical Significance of PD-L1/PD-1 Expression in Gastroenteropancreatic Neuroendocrine Neoplasia.
    Wang C; Yu J; Fan Y; Ma K; Ning J; Hu Y; Niu W; Dong X; Wu Y; Li E; Dong D
    Ann Clin Lab Sci; 2019 Sep; 49(4):448-456. PubMed ID: 31471333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors.
    Kim MJ; Kwon MJ; Kang HS; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Park HC
    Biomed Res Int; 2018; 2018():1013640. PubMed ID: 29780816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Proliferation Markers Ki67 and Phosphohistone-H3 (pHH3) in Breast Ductal Carcinoma In Situ.
    Bosch DE; Kilgore MR; Schmidt RA; Swanson PE; Rendi MH; Chang OH
    Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):543-547. PubMed ID: 28885232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
    McCall CM; Shi C; Cornish TC; Klimstra DS; Tang LH; Basturk O; Mun LJ; Ellison TA; Wolfgang CL; Choti MA; Schulick RD; Edil BH; Hruban RH
    Am J Surg Pathol; 2013 Nov; 37(11):1671-7. PubMed ID: 24121170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of mitosis counting by automated phosphohistone H3 (PHH3) digital image analysis in a breast carcinoma tissue microarray.
    Dessauvagie BF; Thomas C; Robinson C; Frost FA; Harvey J; Sterrett GF
    Pathology; 2015 Jun; 47(4):329-34. PubMed ID: 25938351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma.
    Bedekovics J; Irsai G; Hegyi K; Beke L; Krenács L; Gergely L; Méhes G
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):579-585. PubMed ID: 27997502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinico-morphological analysis of the neuroendocrine neoplasms of the gastroenteropancreatic system.
    Delektorskaya VV; Kozlov NA; Chemeris GY
    Klin Lab Diagn; 2013 Oct; (10):48-50, 10-3. PubMed ID: 24640093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Situ Hybridization Analysis of Long Non-coding RNAs MALAT1 and HOTAIR in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Chu YH; Hardin H; Eickhoff J; Lloyd RV
    Endocr Pathol; 2019 Mar; 30(1):56-63. PubMed ID: 30600442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.